Press Releases

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

Ceryx has strengthened its Board of Directors with the appointment of Mark Strong.

Astoriom Acquires Precision Stability Storage

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

Openwater’s Open-LIFU Device Supports Concierge Mental Health Research with TIESA

TIESA will use Openwater's Open-LIFU platform to support focused ultrasound (FUS) neuromodulation research for depression, anxiety, and other mental health conditions. The Austrian-based company is exploring closed-loop and AI-driven neurostimulation as part of its research programs evaluating non-pharmacologic mental health treatment.

Epigenica Launches EpiFinder™ Analysis Service, a Fully Managed Platform for Fast and Reliable Epigenomic Insights

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform.

ProPharma Sets the Gold Standard in Sustainability with SBTi-Approved Net-Zero Targets

Life Sciences Consulting Leader Validates Science-Based Climate Commitments, Reducing Emissions Across Its Global Operations

START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).

EEDEE Law Expands Clinical Research Support Services and Adds Industry Veteran Helen Montevago to Growing Team

Hovione’s people-first approach recognized as it achieves Top Employer certification for the fourth consecutive year

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Kindeva Announces Leadership Transition to Drive Strategic Growth

From Tokyo to Osaka: PSI Continues Japan Expansion with New Office in Osaka

Gifthealth Announces Jeremy Richardson as New Chief Commercial Officer

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Astoriom Appoints Will Edwards as Chief Executive Officer

Strategic appointment to support global scale-up of sample management operations

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications. The full press release is below.

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials

Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.